Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response

We report the case of a 60-year-old woman with metastatic high-grade uterine leiomyosarcoma who achieved a delayed response to second-line therapy with the marine-derived drug trabectedin (Yondelis®, PharmaMar). We used 2-deoxy-2-[18F] fluorodeoxyglucose (FDG)-positron emission tomography (PET-CT) i...

詳細記述

書誌詳細

出版年:	Case Reports in Oncology
主要な著者:	M.J. Payne, R.E. Macpherson, K.M. Bradley, A.B. Hassan
フォーマット:	論文
言語:	英語
出版事項:	Karger Publishers 2014-02-01
主題:	Sarcoma Trabectedin Delayed response Uterine leiomyosarcoma 18FDG-PET-CT
オンライン･アクセス:	http://www.karger.com/Article/FullText/355224